| PG | prostaglandin |
| LT | leukotriene |
| AA | arachidonic acid |
| GPCR | G-protein-coupled receptor |
| LTB4 | leukotriene B4 |
| PLA2 | phospholipase A2 |
| 5-LO | 5-lipoxygenase |
| COX | cyclooxygenase |
| 5-HpETE | 5-hydroxyperoxyeicosatetraenoic acid |
| LTA4 | leukotriene A4 |
| LTA4H | leukotriene A4 hydrolase |
| LTC4S | leukotriene C4 synthase |
| COPD | chronic obstructive pulmonary disease |
| AMD | age-related macular degeneration |
| BLT1 | LTB4 receptor 1 |
| BLT2 | LTB4 receptor 2 |
| 12-HHT | 12(S)-hydroxyheptadeca-5Z,8E,10E-trienoic acid |
| OXGR1 | oxoglutarate receptor |
| ICS | inhaled corticosteroid |
| AHR | hyper-responsiveness |
| BAL | bronchoalveolar lavage |
| EIA | Exercise-induced asthma |
| LTRA | leukotriene receptor antagonist |
| FLAP | five-lipoxygenase-activating protein |
| EBC | exhaled breath condensate |
| ASA | aspirin-sensitive asthma |
| AERD | aspirin-exacerbated respiratory disease |
| IL | interleukin |
| AR | allergic rhinitis |
| SAH | H1-antihistamines |
| AD | atopic dermatitis |
| MC | mast cell |
| MCAS | mast cell activation syndrome |
| SM | systemic mastocytosis |
| uLTE4 | urinary LTE4 |